Scientists discover fat-burning "switch" that could rival Ozempic

An international team of scientists has identified a biological "switch" that appears to control fat burning in the body. The discovery could lead to a new approach to treating obesity, potentially with fewer side effects than GLP-1 drugs like Ozempic. Researchers believe the mechanism represents a promising new therapeutic target.